Arthur Cox advised Avadel Pharmaceuticals plc (Nasdaq: AVDL). Avadel Pharmaceuticals is a biopharmaceutical company focused on transforming medicines to transform lives. The company’s approach includes applying...
You must be a Standard 1 Year member to access this content.
Arthur Cox advised Avadel Pharmaceuticals plc (Nasdaq: AVDL). Jefferies LLC is acting as the sole book-running manager for the offering. LifeSci Capital LLC is acting as...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Avadel Pharmaceutics on the deal. Avadel announced its royalty agreement with RTW Investments, LP and certain of its affiliates for up to $75 million....
You must be a Standard 1 Year member to access this content.
Goodwin advised Avadel on the deal. Avadel extended the maturity of $96.2 million of its convertible notes to 2027. Under the terms of the convertible note exchange...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Avadel Pharmaceutics plc on the deal. Avadel Pharmaceuticals announced an underwritten public offering of 10,000,001 of its ordinary shares, nominal value $0.01 per...
You must be a Standard 1 Year member to access this content.
Sidley Austin and Quinn Emanuel represented Jazz Pharmaceuticals, while Latham & Watkins, Morrison Foerster and McCarter & English represented Avadel. The Federal Circuit concluded that Jazz...
You must be a Standard 1 Year member to access this content.
